Variant report
Variant | esv3342206 |
---|---|
Chromosome Location | chr7:66844217-66847215 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:66840245..66841805-chr7:66844948..66846496,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544172030 | chr7:66844233-66844234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542480941 | chr7:66844248-66844249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11768598 | chr7:66844253-66844254 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs186358414 | chr7:66844255-66844256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs368994350 | chr7:66844260-66844261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540992616 | chr7:66844308-66844309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571305247 | chr7:66844362-66844363 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538903210 | chr7:66844369-66844370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs140835835 | chr7:66844401-66844402 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs561002176 | chr7:66844410-66844411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563283383 | chr7:66844411-66844412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529038062 | chr7:66844412-66844413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs372876801 | chr7:66844427-66844428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs114202306 | chr7:66844432-66844433 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568511176 | chr7:66844444-66844445 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149846023 | chr7:66844456-66844457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547726505 | chr7:66844489-66844490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs529759055 | chr7:66844494-66844495 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190649655 | chr7:66844562-66844563 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375880335 | chr7:66844573-66844574 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549939905 | chr7:66844575-66844576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2017374 | chr7:66844627-66844628 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs556889616 | chr7:66844628-66844629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75455975 | chr7:66844664-66844665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
25 | rs2017343 | chr7:66844667-66844668 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs555706708 | chr7:66844681-66844682 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572074441 | chr7:66844689-66844690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540778624 | chr7:66844776-66844777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs377103598 | chr7:66844781-66844782 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577208700 | chr7:66844784-66844785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182774839 | chr7:66844816-66844817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548007930 | chr7:66844827-66844828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528527867 | chr7:66844877-66844878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543048266 | chr7:66844910-66844911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs563219096 | chr7:66845016-66845017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs376470814 | chr7:66845017-66845018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs371221751 | chr7:66845026-66845027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs4256486 | chr7:66845040-66845041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542770910 | chr7:66845066-66845067 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187685353 | chr7:66845114-66845115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs527735635 | chr7:66845131-66845132 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547574847 | chr7:66845163-66845164 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs571000284 | chr7:66845219-66845220 | Weak transcription ZNF genes & repeats Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs4718544 | chr7:66845239-66845240 | Weak transcription ZNF genes & repeats Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs4718545 | chr7:66845243-66845244 | Weak transcription ZNF genes & repeats Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs4718546 | chr7:66845309-66845310 | Weak transcription ZNF genes & repeats Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs4718547 | chr7:66845363-66845364 | Weak transcription ZNF genes & repeats Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs555888904 | chr7:66845380-66845381 | Weak transcription ZNF genes & repeats Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537572709 | chr7:66845396-66845397 | Weak transcription ZNF genes & repeats Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs535261427 | chr7:66845398-66845399 | Weak transcription ZNF genes & repeats Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Biliary cancer | 19435499 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Astrocytoma | 22246337 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16461572 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 20668451 | CNVD |
Prostate cancer | 20601956 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Prostate cancer | 21248069 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Prostate cancer | 17297502 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:66843000-66847200 | Enhancers | Fetal Stomach | stomach |
2 | chr7:66843800-66844800 | Weak transcription | Stomach Smooth Muscle | stomach |
3 | chr7:66843800-66845000 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
4 | chr7:66843800-66845000 | Weak transcription | Fetal Lung | lung |
5 | chr7:66843800-66845400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr7:66843800-66845400 | Weak transcription | Spleen | Spleen |
7 | chr7:66844000-66845000 | Weak transcription | Colon Smooth Muscle | Colon |
8 | chr7:66844000-66845000 | Weak transcription | Ovary | ovary |
9 | chr7:66844200-66844800 | Weak transcription | Fetal Muscle Leg | muscle |
10 | chr7:66844800-66845000 | Enhancers | Fetal Muscle Leg | muscle |
11 | chr7:66844800-66845400 | Enhancers | Stomach Smooth Muscle | stomach |
12 | chr7:66845000-66845200 | Enhancers | Colon Smooth Muscle | Colon |
13 | chr7:66845000-66845200 | Enhancers | Duodenum Smooth Muscle | Duodenum |
14 | chr7:66845000-66845200 | Enhancers | Fetal Lung | lung |
15 | chr7:66845200-66845400 | Bivalent Enhancer | Fetal Lung | lung |
16 | chr7:66845200-66845400 | Enhancers | Ovary | ovary |
17 | chr7:66845200-66845600 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
18 | chr7:66845200-66845600 | ZNF genes & repeats | Fetal Kidney | kidney |
19 | chr7:66845200-66846200 | Enhancers | Gastric | stomach |
20 | chr7:66845400-66845600 | ZNF genes & repeats | Spleen | Spleen |
21 | chr7:66845400-66845800 | Bivalent/Poised TSS | Fetal Lung | lung |
22 | chr7:66845400-66846200 | ZNF genes & repeats | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
23 | chr7:66845600-66846000 | Enhancers | Duodenum Smooth Muscle | Duodenum |
24 | chr7:66845600-66846200 | Active TSS | Fetal Kidney | kidney |
25 | chr7:66846200-66846800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |